May 2 (Reuters) - HistoSonics, a medical technology company backed by Johnson & Johnson JNJ.N, is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday, citing people familiar with the matter.
The company is seeking a valuation of more than $2.5 billion, the report said.
(Reporting by Bipasha Dey in Bengaluru; Editing by Sonia Cheema)
((Bipasha.Dey@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。